The epidemiology, diagnosis and treatment of COVID-19.

Antiviral Agents / therapeutic use Betacoronavirus COVID-19 COVID-19 Testing Clinical Laboratory Techniques Clinical Trials as Topic Coronavirus Infections / diagnosis Humans Pandemics Pneumonia, Viral / diagnosis SARS-CoV-2 COVID-19 Drug Treatment
COVID-19 Clinical trials Diagnosis Isolation Pandemic Remdesivir

Journal

International journal of antimicrobial agents
ISSN: 1872-7913
Titre abrégé: Int J Antimicrob Agents
Pays: Netherlands
ID NLM: 9111860

Informations de publication

Date de publication:
May 2020
Historique:
received: 27 02 2020
revised: 16 03 2020
accepted: 19 03 2020
pubmed: 3 4 2020
medline: 29 5 2020
entrez: 3 4 2020
Statut: ppublish

Résumé

In December 2019, the outbreak of the novel coronavirus disease (COVID-19) in China spread worldwide, becoming an emergency of major international concern. SARS-CoV-2 infection causes clusters of severe respiratory illness similar to severe acute respiratory syndrome coronavirus. Human-to-human transmission via droplets, contaminated hands or surfaces has been described, with incubation times of 2-14 days. Early diagnosis, quarantine, and supportive treatments are essential to cure patients. This paper reviews the literature on all available information about the epidemiology, diagnosis, isolation and treatments of COVID-19. Treatments, including antiviral agents, chloroquine and hydroxychloroquine, corticosteroids, antibodies, convalescent plasma transfusion and vaccines, are discussed in this article. In addition, registered trials investigating treatment options for COVID-19 infection are listed.

Identifiants

DOI: 10.1016/j.ijantimicag.2020.105955 PMID: 32234468 PMC: PMC7138178
pubmed: 32234468
pii: S0924-8579(20)30105-9
doi: 10.1016/j.ijantimicag.2020.105955
pmc: PMC7138178
pii:
doi:

Substances chimiques

Antiviral Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105955

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Références

N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
AJR Am J Roentgenol. 2015 Sep;205(3):W267-74
pubmed: 26102309
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Arthritis Rheumatol. 2015 May;67(8):2176-84
pubmed: 25989906
Euro Surveill. 2020 Mar;25(9):
pubmed: 32156330
Hong Kong Med J. 2003 Dec;9(6):399-406
pubmed: 14660806
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Future Microbiol. 2016;11(3):403-25
pubmed: 27028061
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):185-188
pubmed: 32164085
J Clin Virol. 2004 Dec;31(4):304-9
pubmed: 15494274
Emerg Microbes Infect. 2020 Dec;9(1):382-385
pubmed: 32065055
Euro Surveill. 2020 Feb;25(5):
pubmed: 32046819
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1275-1280
pubmed: 32107577
Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
Radiology. 2020 Apr;295(1):202-207
pubmed: 32017661
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Biosci Trends. 2020 Mar 16;14(1):64-68
pubmed: 32037389
Antiviral Res. 2020 May;177:104762
pubmed: 32147496
Clin Infect Dis. 2020 Jul 28;71(15):732-739
pubmed: 32150618
Viruses. 2020 Feb 10;12(2):
pubmed: 32050635
Clin Chim Acta. 2020 Jun;505:172-175
pubmed: 32156607
Sci Transl Med. 2017 Jun 28;9(396):
pubmed: 28659436
Biosci Trends. 2020 Mar 16;14(1):72-73
pubmed: 32074550
Nat Rev Microbiol. 2009 Mar;7(3):226-36
pubmed: 19198616
Nat Med. 2013 Oct;19(10):1313-7
pubmed: 24013700
Clin Infect Dis. 2004 Oct 15;39(8):1247-9
pubmed: 15486852
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
J Infect Dis. 2015 Jan 1;211(1):80-90
pubmed: 25030060
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Mar 12;43(3):203-208
pubmed: 32164089
BMJ. 2020 Feb 19;368:m606
pubmed: 32075786
Front Microbiol. 2018 May 29;9:1101
pubmed: 29896174
Nat Rev Rheumatol. 2020 Mar;16(3):155-166
pubmed: 32034323
J Med Virol. 2020 Jun;92(6):540-545
pubmed: 32108352
Cell Res. 2013 Feb;23(2):300-2
pubmed: 23208422
Lancet. 2020 Mar 7;395(10226):809-815
pubmed: 32151335
J Virol Methods. 2019 Jul;269:49-54
pubmed: 30946852
Curr Opin Virol. 2013 Apr;3(2):170-9
pubmed: 23491947
Lancet Infect Dis. 2020 Apr;20(4):425-434
pubmed: 32105637
N Engl J Med. 2016 Apr 28;374(17):1647-60
pubmed: 25830326
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
Emerg Microbes Infect. 2020 Dec;9(1):378-381
pubmed: 32056509
Int J Antimicrob Agents. 2007 Oct;30(4):297-308
pubmed: 17629679
Life Sci. 2020 May 1;248:117477
pubmed: 32119961
N Engl J Med. 2020 Mar 5;382(10):929-936
pubmed: 32004427
Viruses. 2019 Apr 04;11(4):
pubmed: 30987343
J Hosp Infect. 2020 Mar;104(3):246-251
pubmed: 32035997
J Med Virol. 2020 May;92(5):476-478
pubmed: 32056235
Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6771-6776
pubmed: 32054787
J Clin Microbiol. 2020 Apr 23;58(5):
pubmed: 32132196
N Engl J Med. 2019 Dec 12;381(24):2293-2303
pubmed: 31774950
J Biol Chem. 2020 Apr 10;295(15):4773-4779
pubmed: 32094225
Int J Infect Dis. 2020 Mar;92:214-217
pubmed: 32007643
Front Microbiol. 2017 Jan 09;7:2166
pubmed: 28119682
N Engl J Med. 2016 Jan 7;374(1):33-42
pubmed: 26735992
J Med Virol. 2020 Jun;92(6):538-539
pubmed: 32096564
Emerg Infect Dis. 2020 Jun;26(6):1266-1273
pubmed: 32160149
J Med Virol. 2020 Jun;92(6):556-563
pubmed: 32104907
Expert Rev Mol Diagn. 2017 Feb;17(2):167-180
pubmed: 28043179
J Clin Virol. 2020 Apr;125:104305
pubmed: 32143123
Virol J. 2005 Aug 22;2:69
pubmed: 16115318
J Clin Microbiol. 2015 Aug;53(8):2722-6
pubmed: 26019210
Int J Antimicrob Agents. 2020 Mar;55(3):105923
pubmed: 32070753
Nat Commun. 2020 Jan 10;11(1):222
pubmed: 31924756
Int J Antimicrob Agents. 2020 Apr;55(4):105932
pubmed: 32145363
Lancet. 2020 Feb 15;395(10223):473-475
pubmed: 32043983
Respirology. 2008 Mar;13 Suppl 1:S33-5
pubmed: 18366527
Infect Genet Evol. 2020 Apr;79:104212
pubmed: 32004758
Clin Infect Dis. 2020 Jul 28;71(15):841-843
pubmed: 32047895
Front Med. 2020 Apr;14(2):185-192
pubmed: 32170560
Radiology. 2020 Apr;295(1):22-23
pubmed: 32049600
Radiology. 2020 Aug;296(2):E32-E40
pubmed: 32101510
Eur J Microbiol Immunol (Bp). 2017 Sep 11;7(3):176-186
pubmed: 29034107
PLoS One. 2015 Apr 09;10(4):e0123126
pubmed: 25856093
Euro Surveill. 2020 Mar;25(9):
pubmed: 32156329
Lancet. 2020 Feb 15;395(10223):507-513
pubmed: 32007143
Radiology. 2020 Aug;296(2):E115-E117
pubmed: 32073353
Emerg Microbes Infect. 2020 Dec;9(1):386-389
pubmed: 32065057
Lancet Infect Dis. 2003 Nov;3(11):722-7
pubmed: 14592603
J Med Virol. 2020 Apr;92(4):408-417
pubmed: 31944312
Am J Respir Crit Care Med. 2018 Mar 15;197(6):757-767
pubmed: 29161116
Clin Chem. 2020 Apr 1;66(4):549-555
pubmed: 32031583
Lancet Infect Dis. 2006 Feb;6(2):67-9
pubmed: 16439323
Antimicrob Agents Chemother. 2020 Apr 21;64(5):
pubmed: 32152082
Radiology. 2020 Jun;295(3):715-721
pubmed: 32053470
J Med Chem. 2006 May 4;49(9):2845-9
pubmed: 16640347
Radiology. 2020 Aug;296(2):E41-E45
pubmed: 32049601
J Clin Med. 2020 Feb 07;9(2):
pubmed: 32046137
J Travel Med. 2020 Mar 13;27(2):
pubmed: 32052841
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508

Auteurs

Pan Zhai (P)

Department of Neurology, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, 430073, Hubei, China.

Yanbing Ding (Y)

Department of Neurology, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, 430073, Hubei, China.

Xia Wu (X)

Department of Respiratory Medicine, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, 430073, Hubei, China.

Junke Long (J)

Department of Cardiovascular Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China.

Yanjun Zhong (Y)

ICU Center, The Second Xiangya Hospital, Central South University, Furong, Changsha, Hunan, 41001, China.

Yiming Li (Y)

Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, China. Electronic address: lym-fly@whu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antiviraux › The epidemiology, diagnosis and treatment of COVID-19.
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › The epidemiology, diagnosis and treatment of COVID-19.
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › COVID-19 › The epidemiology, diagnosis and treatment of COVID-19.
questionsmedicales.fr › Techniques d'investigation › Techniques de laboratoire clinique › Dépistage de la COVID-19 › The epidemiology, diagnosis and treatment of COVID-19.
questionsmedicales.fr › Techniques d'investigation › Techniques de laboratoire clinique › The epidemiology, diagnosis and treatment of COVID-19.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études cliniques comme sujet › Essais cliniques comme sujet › The epidemiology, diagnosis and treatment of COVID-19.
questionsmedicales.fr › Infection › Maladies virales › Infections à virus à ARN › Infections à Nidovirales › Infections à Coronaviridae › Infections à coronavirus › The epidemiology, diagnosis and treatment of COVID-19.
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › The epidemiology, diagnosis and treatment of COVID-19.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Épidémies de maladies › Épidémies › Pandémies › The epidemiology, diagnosis and treatment of COVID-19.
questionsmedicales.fr › Maladies de l'appareil respiratoire › Infections de l'appareil respiratoire › Pneumopathie infectieuse › Pneumopathie virale › The epidemiology, diagnosis and treatment of COVID-19.
questionsmedicales.fr › Virus › Virus à ARN › Virus à ARN à brin positif › Nidovirales › Coronaviridae › Coronavirus › Betacoronavirus › Virus du SRAS › SARS-CoV-2 › The epidemiology, diagnosis and treatment of COVID-19.
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Traitements médicamenteux de la COVID-19 › The epidemiology, diagnosis and treatment of COVID-19.